Last Updated: 09/12/2024
Understanding the potential role of LSA3, a novel malaria vaccine candidate, during erythrocyte invasion by Plasmodium falciparum
Objectives
The goal of this study is to investigate the role of the malaria vaccine candidate protein LSA3 in the red blood cell invasion process of Plasmodium falciparum. By examining the effects of LSA3 deletion on parasite growth and invasion timing, the study aims to understand the functional importance of LSA3, particularly its role in the late stages of red blood cell invasion, which may have implications for developing effective malaria vaccines.
Genetic deletion of the malaria vaccine candidate protein LSA3 reduced the growth rate of the blood-stage Plasmodium falciparum parasites. Time-lapse imaging during red blood cell invasion suggested that the LSA3 deficient parasite had a delayed invasion compared to the wild-type parasite. In addition, endogenous LSA3 was secreted at late stages of red blood cell invasion and localized at the posterior part of the invading merozoite. These findings suggest that LSA3 plays important roles in the late stages of red blood cell invasion by Plasmodium falciparum.
Apr 2018 — Mar 2020
$39,267


